跳至主要内容
临床试验/NCT01332773
NCT01332773Unknown3 期

The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer

Heidelberg University2 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
3 期
入组人数
124
试验地点
2
主要终点
Rate of R1 resections

研究概览

简要总结

To show whether the artery first approach leads to equal or less rate of positive resection margins in pancreatic head cancer than the standard technique (ppWhipple only with standard Kocher's manoeuvre)

详细描述

This is a prospective non-randomized trial with two study groups. The trial is designed to show if the ARTERY FIRST approach reduces the rate of R1 resections in patients undergoing surgery for cancer of the pancreatic head.

After the diagnosis of cancer of the pancreatic head by clinical, laboratory and imaging evaluation patients who are scheduled for resection will be screened for inclusion into the trial. Informed consent is obtained at least on the day before surgery and patients meeting the eligibility criteria will be enrolled into the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pancreatic head cancer (diagnosis by clinical, laboratory and radiological evaluation)
  • Patients scheduled for curative resection
  • No evidence of distant metastases
  • Age equal or greater than 18 years
  • Informed consent

排除标准

  • Expected lack of compliance
  • Impaired mental state or language problems
  • patient having had neoadjuvant radiochemotherapy

结局指标

主要结局

Rate of R1 resections

时间窗: up to 1.5 years

positive resection margins as described by the pathologists of the University of Heidelberg

次要结局

  • Exploratory analyses(up to 1.5 years)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验